Global Clinical Trial Investigative Site Network Market

Report ID : 1486 | Published : 2022-12-02 | Pages: | Format: PDF/EXCEL

The market size of the Global Clinical Trial Investigative Site Network Market in the year 2021 is valued at 7.18 billion and is predicted to reach 13.09 billion by the year 2030 at an 7.12% CAGR during the forecast period.

The regulatory role is supported, participant enrollment is improved, data management is facilitated, and quality assurance is facilitated using a clinical trial investigative site network. It contributes to quicker trial initiations and shorter trial timeframes while increasing process compliance and reducing difficulties with each trial. These elements support the demand for networks of clinical investigative sites. The increased number of clinical trials is rising due to increased R&D spending and the desire for innovative therapies for uncommon diseases, which is, in turn, increasing the demand for clinical trial investigative site network services. The need for complex research and innovative treatments is being driven by the rising burden of diseases around the world, which is also anticipated to spur growth in these fields.

Since managing research sites and conducting clinical trials can be improved, pharmaceutical industry innovators are constantly coming up with new ideas. Outsourcing various trial operations to a specialist service provider, like site management organizations (SMOs), has emerged as a practical option for many developers among the alternatives. Employing such specialized service providers has many benefits, including helping sponsors meet their clinical research timeframes. A sizable growth rate is projected for the worldwide clinical investigative site network market. The accessibility of sites and the growing global reach of clinical trials are to blame for the growth.

Market Segmentation:

The clinical trial investigative site network market is segmented on the therapeutic area, phase and end-use. Based on the therapeutic area, the market is segmented into oncology, cardiology, CNS, pain management, endocrine and others. Based on phase, the clinical trial investigative site network market is segmented into Phase I, II, III and IV. Based on the end users, the clinical trial investigative site network market is segmented into sponsor and CRO.

Based on the therapeutic area, the oncology segment is a major contributor to the clinical trial investigative site network market.

The market's leading segment is oncology. The high frequency of various types of cancer and the surge in financing for oncology-related research are driving the segment's expansion. Clinical research on new anti-cancer medications and therapies is also expanding. As more individuals lead sedentary lifestyles, cancer cases will likely increase in the upcoming years. The rising prevalence of cancer cases will significantly increase the need for cutting-edge anti-cancer therapies, driving up the number of oncology-based clinical trials and fostering industrial expansion simultaneously.

The phase III segment witnessed growth at a rapid rate.

Phase III grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the expected time. Phase III clinical studies are more complex than those in earlier phases and involve a more significant number of patients. Therefore, there is a greater need for clinical trial investigative site networks in this stage of clinical trials. As a result of the sample size and research design, which call for precision dosing at an ideal level, this phase also has the highest failure rate.

The North American clinical trial investigative site network market holds a significant revenue share in the region.

The North American clinical trial investigative site network market is expected to register the highest market share. This high proportion can be attributed to pharmaceutical companies in the US and Canada investing more in clinical research. Further, it is anticipated that positive government support for clinical trials in the United States will boost consumption of the home machine of clinical trial investigation sites. Besides, the Asia Pacific region is estimated to hold the second-largest share of the market. Due to the ease of regulatory compliance, low study expenses, increasing patient population, and a few premier clinical institutions serving as sites, the area has become a hotspot for clinical trials.

Competitive Landscape

Some major key players in the Clinical Trial Investigative Site Network market are ICON Plc, Meridian Clinical Research, IQVIA Inc., Clinedge, WCG, ClinChoice, Access Clinical Research, FOMAT Medical Research, Inc., SGS, KV Clinical, SMO-Pharmina, Xylem Clinical Research, and Aurum Clinical Research.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Clinical Trial Investigative Site Network Market Snapshot

Chapter 4. Global Clinical Trial Investigative Site Network Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Therapeutic Areas Estimates & Trend Analysis

5.1. by Therapeutic Areas & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Therapeutic Areas:

5.2.1. Oncology

5.2.2. Cardiology

5.2.3. CNS

5.2.4. Pain Management

5.2.5. Endocrine

5.2.6. Others

Chapter 6. Market Segmentation 2: by Phase Estimates & Trend Analysis

6.1. by Phase & Market Share, 2019 & 2030

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Phase:

6.2.1. Phase I

6.2.2. Phase II

6.2.3. Phase III

6.2.4. Phase IV

Chapter 7. Market Segmentation 3: by End-use Estimates & Trend Analysis

7.1. by End-use & Market Share, 2019 & 2030

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by End-use:

7.2.1. Sponsor

7.2.2. CRO

Chapter 8. Clinical Trial Investigative Site Network Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2022-2030

8.1.2. North America Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2022-2030

8.1.3. North America Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2022-2030

8.1.4. North America Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.2. Europe

8.2.1. Europe Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2022-2030

8.2.2. Europe Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2022-2030

8.2.3. Europe Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2022-2030

8.2.4. Europe Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2022-2030

8.3.2. Asia Pacific Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2022-2030

8.3.3. Asia-Pacific Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2022-2030

8.3.4. Asia Pacific Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.4. Latin America

8.4.1. Latin America Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2022-2030

8.4.2. Latin America Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2022-2030

8.4.3. Latin America Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2022-2030

8.4.4. Latin America Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2022-2030

8.5.2. Middle East & Africa Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2022-2030

8.5.3. Middle East & Africa Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2022-2030

8.5.4. Middle East & Africa Clinical Trial Investigative Site Network Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. ICON Plc

9.2.2. Meridian Clinical Research

9.2.3. IQVIA Inc.

9.2.4. Clinedge

9.2.5. WCG

9.2.6. ClinChoice

9.2.7. Access Clinical Research

9.2.8. FOMAT Medical Research, Inc.

9.2.9. SGS

9.2.10. KV Clinical

9.2.11. SMO-Pharmina

9.2.12. Xylem Clinical Research

9.2.13. Aurum Clinical Research

9.2.14. Other Prominent Players

By Therapeutic Areas

  • Oncology
  • Cardiology
  • CNS
  • Pain Management
  • Endocrine
  • Others

By Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By End-use

  • Sponsor
  • CRO

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients